Role of anlotinib plus albumin paclitaxel regimen in stage IV non-small cell lung cancer and mental state
Anlotinib combined with albumin-paclitaxel demonstrated therapeutic efficacy in stage IV NSCLC, reducing depression, anxiety, and tumor biomarker levels, while enhancing immune function, prolonging survival, and improving quality of life.
Authors
- Jianghong Liu (ORCID: https://orcid.org/0000-0002-8405-6153)
- Shuqin Cheng
- Yunfang Zhao
- Wei Zhang (ORCID: https://orcid.org/0000-0003-0875-263X)
- Yanfeng Wu (ORCID: https://orcid.org/0000-0002-6320-8832)
- Xiaoxia Liu (ORCID: https://orcid.org/0000-0002-3673-4271)
- J.Q. Hao (ORCID: https://orcid.org/0009-0000-7868-1107)
- Feifei Liang
Institutions
- Hebei North University (CN)
- Hospital of Hebei Province (CN)
- Zhangjiakou Academy of Agricultural Sciences (CN)
- Wuhan University of Science and Technology (CN)
Publication Details
- Journal
- World Journal of Psychiatry
- Published
- 2025-08-08
- DOI
- https://doi.org/10.5498/wjp.v15.i8.103735
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00